Skip to main content
Signal8
PRINS RICHARD K profile photo

Richard K. Prins

CIK: 0001047579

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (21.1%)

Position reduction

Option Exercises (M)9 (47.4%)

Derivative conversions

Awards (A)3 (15.8%)

Compensation grants

Other (G, F, J, C, D, …)3 (15.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Amphastar Pharmaceuticals, Inc. logo
AMPH

Amphastar Pharmaceuticals, Inc.

Director
IGC Pharma, Inc. logo
IGC

IGC Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (19 total)

  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Aug 11, 2026
    Sale(S)
    Direct
    8K shares at avg. $20.30$162K
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Jun 1, 2026
    Award(A)
    Direct
    8.1K shares-
  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Apr 1, 2026
    Exercise(M)
    Direct
    100K shares-
  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Apr 1, 2026
    Exercise(M)
    Direct
    70K shares-
  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Jan 19, 2026
    Exercise(M)
    Direct
    100K shares-
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Nov 25, 2025
    Sale(S)
    Direct
    4.2K shares at avg. $27.10$113K
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Nov 25, 2025
    Exercise(M)
    Direct
    4.2K shares at avg. $16.69$70K
  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Oct 17, 2025
    Award(A)

    Options

    Direct
    750K shares-
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Jun 2, 2025
    Award(A)
    Direct
    5.1K shares-
  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Mar 31, 2025
    Exercise(M)
    Direct
    58.3K shares-
  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Mar 31, 2025
    Exercise(M)
    Direct
    100K shares-
  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Mar 31, 2025
    Exercise(M)
    Direct
    70K shares-
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Dec 9, 2024
    Gift(G)
    Direct
    410 shares-
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Dec 9, 2024
    Exercise(M)
    Direct
    10K shares at avg. $19.52$195K
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Dec 9, 2024
    Sale(S)
    Direct
    10K shares at avg. $43.77$438K
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Nov 12, 2024
    Exercise(M)
    Direct
    2.5K shares at avg. $16.69$42K
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Nov 12, 2024
    Gift(G)
    Direct
    1K shares-
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Nov 12, 2024
    Sale(S)
    Direct
    5K shares at avg. $48.80$244K
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Aug 19, 2024
    Gift(G)
    Direct
    1.5K shares-

1-19 of 19

About PRINS RICHARD K

PRINS RICHARD K (SEC CIK 0001047579) files insider reports with the SEC as Director of Amphastar Pharmaceuticals, Inc. (AMPH) and Director of IGC Pharma, Inc. (IGC).

Signal8 holds 10 ownership filings by PRINS RICHARD K (9 Form 4, 1 Form 5), filed between Nov 13, 2024 and Aug 12, 2026. Those filings report 19 transactions, from Aug 19, 2024 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on PRINS RICHARD K's filings is in RANCHO CUCAMONGA, CA.

Recent filings by PRINS RICHARD K

  • Aug 11, 2026: Open-market sale of AMPH shares (Form 4, code S).
  • Jun 1, 2026: Grant or award of AMPH shares (Form 4, code A).
  • Apr 1, 2026: Option exercises of IGC shares (2 lines, Form 4, code M).
  • Jan 19, 2026: Option exercise of IGC shares (Form 4, code M).
  • Nov 25, 2025: Open-market sale of AMPH shares (Form 4, code S).

Other insiders filing for Amphastar Pharmaceuticals, Inc. (AMPH)

How to read Form 4 transaction codes